CR

Carmichael Roberts

Entrepreneur | Founder & Managing Partner at Material Impact

Greater Boston

Invests in

Stages:

  • Min Investment:

    $500,000.00
  • Max Investment:

    $50,000,000.00
  • Target Investment:

    $25,000,000.00

Education

Work Experience

  • Founder and Managing Partner

    2016

    Material Impact transforms materials into companies that make an impact.

  • Director

    2014

  • Chairman Of The Board

    2013

  • Co-founder and Chairman of the Board

    2008

    Co-founded and serve as Chairman of the Board. Sourced the technology out of the University of Illinois. Incubated the platform at the offices at North Bridge. Recruited and hired the executive team.

  • Chairman Of The Board

    2008

    Served as Chairman of the Board since inception. Scouted the technology out of MIT and worked closely with the CEO to recruit and hire the managing team. Developed the strategy to collaborate with large corporates.

  • Co-Founder and Chairman of the Board

    2007

    Established a creative hybrid non-profit and for-profit business model in conjunction with Harvard University. Recruited the business and technical team. Crafted the strategy for commercial launch of diagnostic devices including a close collaboration with the Gates Foundation, the organization’s flagship funder.

Arsenal Medical

2005

  • Co-Founder and Lead Director

    2005

    Co-Founded and recruited the initial thirty member team, including the CEO, CTO, VP of Business Development, and VP of Engineering. Raised the initial $20 million from top-tier venture capital firms and guided the company on its initial commercial applications in trauma, blood vessel and joint repair.

2009 - 2018

  • Lead Director

    2009 - 2018

    Co-founded and served as Chairman of the Board from the company's inception. Worked closely with the CEO to scout the technology platform, recruit and hire the managing team and develop the strategy for collaboration with large companies.

  • Co-Founder and Chairman of the Board

    2005 - 2018

    Hired key scientists and recruited a stellar executive team from the executive ranks at Genzyme and Boston Scientific. Built the investor syndicate including Medtronic, a critical strategic company that sits on the board.